Cabotegravir sodium 卡博特韦钠; GSK-1265744 sodium; S/GSK1265744 sodium,99.82%
产品编号:Bellancom-15592A| CAS NO:1051375-13-3| 分子式:C19H16F2N3NaO5| 分子量:427.33
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
Cabotegravir sodium 卡博特韦钠; GSK-1265744 sodium; S/GSK1265744 sodium
产品介绍 | Cabotegravir (GSK-1265744) sodium 一种具有口服活性且长效的HIV 整合酶 (HIV integrase) 链转移抑制剂,也是有机阴离子转运蛋白 1/3 (OAT1/OAT3) 抑制剂,对HIVADA、OAT3 和 OAT1 的 IC50 分别为 2.5 nM、0.41 μM 和 0.81 μM。Cabotegravir sodium 主要由尿苷二磷酸葡萄糖醛酸转移酶 (UGT) 1A1 代谢,与其他抗逆转录病毒活性分子 (ARVs) 相互作用的可能性较低。Cabotegravir sodium 可用于艾滋病 (AIDS) 的研究。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | Cabotegravir (GSK-1265744) sodium is a orally active and long-acting HIV integrase strand transfer inhibitor and organic anion transporter 1/3 (OAT1/OAT3) inhibitor with IC50 values of 2.5 nM, 0.41 μM and 0.81 μM for HIVADA, OAT3 and OAT1, respectively. Cabotegravir sodium is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1, with low potential to interact with other antiretroviral agents (ARVs). Cabotegravir sodium can be used to research AIDS. | ||||||||||||||||
体外研究 |
Cabotegravir (GSK-1265744) 在体外抑制 HIV-1 整合酶催化的链转移反应,IC50 为 3.0 nM。在 PBMCs中对 HIV-1 Ba-L 的抗病毒 EC50为 0.22 nM,对 NL432 的EC50 为 0.34 nM。在 MT-4 细胞中,用CellTiter-Glo测得的EC50 为 0.57 nM, MTT测得的EC50 为1.3 nM,在使用伪型自灭活病毒的 PHIV 测定中EC50为0.5 nM。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability Assay
|
||||||||||||||||
体内研究 (In Vivo) |
Cabotegravir 在小鼠中的半衰期长达 54 天。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
Cabotegravir 在小鼠中的半衰期长达 54 天。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
Cabotegravir 在小鼠中的半衰期长达 54 天。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 6.9 mg/mL (16.15 mM; ultrasonic and warming and heat to 60°C) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
参考文献 |
|